meningitis%20-%20acute,%20bacterial
MENINGITIS - ACUTE, BACTERIAL

Acute meningitis is the infection of the subarachnoid space and cerebrospinal fluid by bacteria that may cause local and systemic inflammatory response.
There is the classic triad of symptoms of fever, neck stiffness and altered level of consciousness.
Other symptoms include chills, myalgia, photophobia, severe headache, focal neurologic symptoms, nausea, vomiting, seizures and some patients may present with rash.

 

Definition

  • Meningitis is the infection of the meninges and subarachnoid space that is usually caused by bacteria results in high mortality and morbidity throughout the world

Etiology

  • The introduction of conjugated vaccines against H influenzae type B, N meningitidis and S pneumoniae caused decline in the incidence of bacterial meningitis in children thus majority of cases are now present in the adult population
  • Causative agents depend on the age of the patient and predisposing factors

Other causes of acute meningitis include the following:

  • Spirochetes eg Treponema pallidum
  • Mycobacteria eg Mycobacterium tuberculosis
  • Fungi eg Cryptococcus, Coccidioides, Sporothrix
  • Viruses eg herpes simplex virus (HSV), varicella zoster, cytomegalovirus (CMV), enterovirus
  • Protozoa and helminths

Signs and Symptoms

  • Classic triad: Fever, neck stiffness and an altered level of consciousness is present in <50% of cases as some may have severe headache (especially in children) or any of the other symptoms:
    • Chills
    • Myalgia
    • Photophobia
    • Focal neurologic symptoms [eg cranial nerve palsies, ataxia, dilated/unequal and poorly reacting pupils (late sign)]
    • Nausea/vomiting
    • Seizures (late sign)
    • Some patients may present with petechial rash

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, Yesterday

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 2 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.